Regev Cohen
Overview
Explore the profile of Regev Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
841
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azuly H, Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, et al.
Infect Dis Ther
. 2024 Dec;
14(1):167-180.
PMID: 39652286
Introduction: Despite the declining public health emergency status, COVID-19 still poses significant risks, especially for immunocompromised individuals. We aimed to evaluate the effectiveness of tixagevimab-cilgavimab (T-C) prophylaxis in preventing severe...
2.
Cohen R
Infect Prev Pract
. 2024 Dec;
6(4):100420.
PMID: 39639937
Central venous catheters (CVCs) are essential in modern healthcare but are associated with significant risks, particularly catheter-related bloodstream infections (CRBSIs). Current guidelines do not recommend routine replacement of CVCs based...
3.
Cohen R, Lipman-Arens S, Mahamid L, Ishay L, Feld Simon O, Reisfeld S, et al.
Am J Infect Control
. 2024 Oct;
53(3):361-367.
PMID: 39427926
Background: The risk of central line-associated bloodstream infection (CLABSI) is associated with central venous catheter (CVC) dwelling time. We implemented a hospital-wide intervention aimed to alert physicians to CVC duration...
4.
Massalha M, Mahamid L, Ishay L, Freimann S, Cohen R, Reisfeld S
Diagn Microbiol Infect Dis
. 2024 Jul;
110(1):116366.
PMID: 39002447
Purpose: Appropriate antimicrobial therapy and surgical drainage, improve survival in patients with Gram negative bloodstream infections (BSI). Data about the yield of imaging studies in polymicrobial BSI is sparse. The...
5.
Tannous E, Lipman-Arens S, Cohen R
Clin Infect Dis
. 2024 Mar;
79(4):1120-1121.
PMID: 38446985
No abstract available.
6.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, et al.
Cancer Med
. 2024 Feb;
13(3):e6997.
PMID: 38400683
Objectives: Hematological malignancy (HM) patients treated with anti-CD20 monoclonal antibodies are at higher risk for severe COVID-19. A previous single-center study showed worse outcomes in patients treated with obinutuzumab compared...
7.
Lipman-Arens S, Finn T, Istomin V, Cohen R, Reisfeld S
Vector Borne Zoonotic Dis
. 2024 Feb;
24(5):293-298.
PMID: 38306181
Q fever has significant consequences for patients with persistent localized infection. A combination of doxycycline with hydroxychloroquine, for at least 18-24 months, is the first-line therapy. The use of serology...
8.
Cohen R, Tannous E, Natan O, Vaknin A, Ganayem M, Reisfeld S, et al.
Am J Infect Control
. 2024 Jan;
52(6):664-669.
PMID: 38232901
Background: Blood cultures (BCs) are essential microbiologic tests, but blood culturing diagnostic stewardship is frequently poor. We aimed to study the process-related failures and to evaluate the effect of an...
9.
Biran R, Cohen R, Finn T, Brosh-Nissimov T, Rahav G, Yahav D, et al.
Emerg Infect Dis
. 2023 Jun;
29(7):1297-1301.
PMID: 37347492
We report an outbreak of Candida auris across multiple healthcare facilities in Israel. For the period of May 2014-May 2022, a total of 209 patients with C. auris infection or...
10.
Rubin-Blum M, Harbuzov Z, Cohen R, Astrahan P
Sci Total Environ
. 2023 May;
887:164108.
PMID: 37178839
Antibiotic resistance (AMR) in pathogens threatens human health worldwide, and antibiotic-resistant bacteria (ARB) are widespread in the environment. In particular, anthropogenically-disturbed rivers became reservoirs of ARBs and hotspots of antibiotic...